Results 1 to 10 of about 2,249,719 (290)

YAP1 Dysfunction Promotes Molecular Properties Linked to Breast Cancer Susceptibility. [PDF]

Cancer Prev Res (Phila)
Fresques T, Lopez JC, Hussey D, Miyano M, Garbe JC, Hinz S, Sayaman RW, Li A, Schmolze D, Van Bedford S, Stampfer MR, LaBarge MA.   +11 more
europepmc   +1 more source

A novel gene signature based on Like-Smith family members-related genes for predicting the prognosis of hepatocellular carcinoma. [PDF]

Transl Cancer Res
Chen S, Chen X, Sun X, Wu S.
europepmc   +1 more source

Threshold Signatures

IEEE Security & Privacy
openaire   +1 more source

A novel prognostic signature based on epithelial-mesenchymal transition-associated genes for the prognosis and immune status in breast cancer. [PDF]

Am J Transl Res
Wu Z, Zheng J, Men S, Sui S, Yan W, Liu Y, Han M.   +6 more
europepmc   +1 more source

Integrative multi-omic analysis identified <i>ERBB2</i> mutations and senescence-driven immune suppression as dual therapeutic targets in LAR triple-negative breast cancer. [PDF]

Cancer Biol Med
Zhao Y, Wang H, Wang Y, Jiang Y, Hu X, Shao Z.   +5 more
europepmc   +1 more source

From a Multi-Omics Signature to a Therapeutic Candidate: Computational Prediction and Experimental Validation in Liver Fibrosis. [PDF]

Pharmaceuticals (Basel)
Qin Y, Ma S, Hong H, Zhong D, Liang Y, Su Y, Chen Y, Chen X, Zhu Y, Huang X.   +9 more
europepmc   +1 more source

Retraction: A transcriptional signature associated with non-Hodgkin lymphoma in the blood of patients with Q fever. [PDF]

PLoS One
PLOS One Editors.
europepmc   +1 more source

Integrating tumor and immune cell transcriptomics to predict immune checkpoint inhibitor primary resistance in metastatic melanoma. [PDF]

Oncoimmunology
Onieva JL, Pérez-Ruiz E, Vilkki V, Berciano-Guerrero M, Figueroa-Ortiz L, Zalabardo M, Martínez-Gálvez B, Barragán I, Rueda-Domínguez A.   +8 more
europepmc   +1 more source